Eric E. Harrison, MD

USA Camostat/Bromhexine COVID-19 Public Health Research Group

Sector Strategist, Prevention & Health Research, Biomedical Science,

Patient-Centered Ecosystems, Harrison Cognitive Lab,

Cardio-Oncology , PrivaCors Inc,  Cardio-Orthopaedics ®

Cardiology, Advanced Cardiac Imaging,

Collaborative Professor of Medicine

Dr. Harrison attended Vanderbilt University on a Founder’s Scholarship as a National Merit Semi-Finalist and received his Bachelor of Science Degree from Rollins College after completing an accelerated three-year program. He spent a year in medical research at the University of Kentucky Medical School where he then attended medical school. While in medical school at the University of Kentucky, he studied law at the University of Tennessee in Knoxville. He received his medical degree from the University of Kentucky and completed internship, Internal Medicine residency and Cardiology Fellowship at the University of South Florida where he was a Special Fellow of the Florida Heart Association. He was acting Director of the Cath Lab at the VA Hospital for 3 months prior to finishing his training. He is a founding physician of the University of South Florida Medical School. He was co-director of the Cardiology Center at Tampa General Hospital for thirteen years and directed noninvasive cardiology for seven years where he started echocardiography and nuclear cardiology. At Tampa General he performed over 14,000 heart catheterizations, numerous coronary angioplasties, cardiac electrophysiologic studies and myocardial biopsies and was a transplant cardiologist on the transplant team for three years. He and his colleagues started the first outpatient cardiovascular health center in Tampa at Memorial Hospital where he is currently the Medical Director and where he has directed the cardiac rehabilitation program. His non-invasive cardiology interests are 3D echo, multi-slice CAT scan imaging of the coronaries, Cardiac PET/CT, Cardiac MRI, and hybrid imaging. Dr. Harrison received the Founder’s Scholarship to Vanderbilt University, a grant from the Florida Heart Association as a special cardiac Fellow and a grant from the Florida Regional Medical Program to study sudden death. He and his associates originated the paramedic services of Tampa Fire Rescue and Hillsborough County Medical Services and he served as Medical Director for each service for many years. He was also given the key to the City of Tampa by Tampa Mayor Dick Greco for his work with the Fire Rescue paramedics and was honored by Hillsborough County EMS for his founding work when he was a cardiac fellow. He has served in many administrative positions, voluntary groups and government organizations. Among his administrative responsibilities, he was the managing partner of an 11-physician cardiology group and medical service organization for several years. Dr. Harrison is currently the National Director of Advanced Cardiac Imaging of Iasi Healthcare Inc .  which owns and operates 15 acute care hospitals in Florida, Texas, Louisiana, Utah, Arizona, and Nevada. Dr. Harrison was one of first to use the therapeutic hypothermia for Cardiac Arrest patients. He began to use this treatment clinically shortly after the landmark articles were published in February 2002. He is currently integrating hypothermic medicine into the IASIS healthcare system. He has served as a consultant for many national companies associated with cardiac imaging. Dr. Harrison started and directs the Joint Memorial Hospital / University of South Florida Medical School Advanced Cardiac Imaging Program for practicing physicians, cardiac fellows, and medical student training. He is a preceptor for the University of South Florida Medical School, Saba University Medical School of the Netherland Antilles, CSU College of Pharmacy in Chicago, and Midwestern University College of Pharmacy.

Karen Davidson DHA, MSA, MEd., MSN, RN

Vice President of Sales, North America, GM Instruments, Ltd.

Dr. Karen Davidson graduated from the University of North Carolina at Chapel Hill School of Nursing and Central Michigan University. She has held many positions in the medical device industry over the past 24 years, specifically in the ENT and Sleep markets, in addition to 28 years of clinical experience to include service as a Flight Nurse in the United States Air Force Reserves and a committee member for various Otolaryngology meetings. Dr. Davidson serves as the Vice President at GM Instruments, Ltd. with a special interest in and published on the technology of objective nasal measurements, nasal physiology, clinical application, reimbursement, health economics, and health policy. She is adjunct faculty at Central Michigan University, Health Administration Division, School of Health Professions and Liberty University, School of Health Sciences, and a member of the American College of Healthcare Executives. Research interests and expertise as a partner with the Harrison COVID-19 Research Group include nasal function studies, nasal physiology, nasal drug delivery, health economics, and health policy.

Nghia Ho, MD

USA Camostat/Bromhexine COVID-19 Public Health Research Group

Medical Editor, Cardio-Orthopaedics ®

Dr. Nghia (Nick) Ho graduated from UCI before travelling the world and starting his medical background in Germany and the Ukraine before transferring to the Caribbean and finishing his clinical education in the USA. Having graduated from St. Matthews University in Grand Cayman, he has the last decade in medical informatics and clinical information research before heading back into the clinical realm. He is currently co-editing Cardio-Orthopaedics with Dr. Eric E. Harrison and group as well as helping to integrate his skills and background with Harrison’s COVID-19 Research Group. He is also associate adjunct professor (preceptor) for Midwestern University College of Pharmacy and CSU College of Pharmacy.

Doraida Abramowitz, DMD

USA Camostat/Bromhexine COVID-19 Public Health Research Group

Dr. Doraida Abramowitz graduated from Nova Southeastern University with a Bachelor of Science degree prior to pursuing her Doctorate of Dental Medicine from the University of Pittsburgh School of Dental Medicine. Following dental school, she completed an AEGD Residency at the University of Florida and later obtained a Certificate of Advanced Graduate Studies in Orthodontics and Dentofacial Orthopedics at Jacksonville University. Dr. Abramowitz is on a mission to make a positive impact in health care and the wellness of others.

Hamza Paracha, MD 

USA Camostat/Bromhexine COVID-19 Public Health Research Group

Dr. Hamza Paracha is a Clinical Research Associate at Harrison Research Group originally from Calgary, Canada. Dr. Paracha earned his medical degree from the International American University College of Medicine, Saint Lucia. He has special clinical interests in Advanced Cardiac Imaging for screening and prevention of cardiovascular disease in primary care patients. Dr. Paracha is leading our research team in seeking and submitting grant proposals including the Rockefeller Foundation for our Bromhexine Cocktail for COVID-19 Prophylaxis. Apart from research, Dr. Paracha volunteers remotely for the Canada Suicide Prevention Services as well as partakes in medical missions abroad.

Christopher J. Augustine, BS

Executive Director and Coordinator of Global Bromhexine and Camostat Public Health Research Group

CJ Augustine is from Tampa, FL and is a proud alumnus of Florida State University (’19) where he received his Bachelor of Science in Exercise Physiology. CJ is passionate about using his interests in health and wellness as a vehicle to help those in need and to build meaningful and lasting relationships with each person and colleague he encounters. Mr. Augustine enjoys that his position as Executive Director and Coordinator of Global Protease Inhibitor COVID-19 Public Health Research Group as well as in the USA Protease Inhibitor COVID-19 Public Health Research Group allows him to exercise both his passion for people and their wellbeing to advance the progression of effective protocol and treatment for the COVID-19 virus in the community and around the world. CJ is grateful to be working under the guidance of Dr. Harrison and with the entire team as they continue their efforts to overcome this pandemic and save lives.